Literature DB >> 32082797

Relationship of genetic factors with development of aortic dissection and aneurysm.

Rıfat Özmen1, Aydın Tunçay2, Elif Funda Şener1, Ömer Naci Emiroğulları2.   

Abstract

BACKGROUND: This study aims to investigate the relationship between the development of aortic dissections and aneurysms with the polymorphisms of angiotensin converting enzyme gene, methylenetetrahydrofolate reductase gene, plasminogen activator inhibitor-1 gene, and nitric oxide synthase gene.
METHODS: Between April 2009 and July 2014, 38 patients with aortic dissections (28 males, 10 females; mean age 55.1±10.7 years; range, 30 to 78 years) and 67 patients with aortic aneurysms (57 males, 10 females; mean age 63.0±11.4 years; range, 31 to 82 years) were included in this cross-sectional study. The control group consisted of 60 healthy volunteers (41 males, 19 females; mean age 56.3±11.2 years; range, 30 to 82 years) without an aortic aneurysm or dissection, as assessed by thoracoabdominal computed tomography. The prespecified four genes were genotyped with competitive allelespecific polymerase chain reaction.
RESULTS: The aortic dissection group had higher nitric oxide synthase-3 (4b/4b) expression levels, compared to the control group. The aortic aneurysm group had also higher nitric oxide synthase-3 (4b/4a) expression levels, compared to the control group. Compared to the control group, a higher rate of angiotensin converting enzyme I/D gene polymorphism was detected in the aneurysm group, while higher D/D polymorphism rates were found in the dissection group; although not statistically significant.
CONCLUSION: Our study results suggest that the nitric oxide synthase-3 intron 4b/4b and nitric oxide synthase-3 intron 4b/4a gene polymorphisms can be used as a predictor of aortic dissection and aneurysm development.
Copyright © 2018, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Aortic aneurysm; NOS3; aortic dissection; genetic; nitric oxide synthase-3; polymorphism

Year:  2018        PMID: 32082797      PMCID: PMC7018176          DOI: 10.5606/tgkdc.dergisi.2018.16424

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  24 in total

1.  Lack of evidence for contribution of Glu298Asp (G894T) polymorphism of endothelial nitric oxide synthase gene to plasma nitric oxide levels.

Authors:  Jesung Moon; Suin Yoon; Eunkyung Kim; Chol Shin; Sangmee Ahn Jo; Inho Jo
Journal:  Thromb Res       Date:  2002-08-15       Impact factor: 3.944

2.  The role of TNF-α and PAI-1 gene polymorphisms in familial Mediterranean fever.

Authors:  Munis Dundar; Aslihan Kiraz; Burhan Balta; Elif Funda Emirogullari; Gokmen Zararsiz; Alper Yurci; Duran Aslan; Mevlut Baskol
Journal:  Mod Rheumatol       Date:  2012-06-27       Impact factor: 3.023

3.  Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.

Authors:  J I Rossaak; A M Van Rij; G T Jones; E L Harris
Journal:  J Vasc Surg       Date:  2000-05       Impact factor: 4.268

4.  Deletion polymorphism in the gene for angiotensin-converting enzyme is not a risk factor predisposing to abdominal aortic aneurysm.

Authors:  K Hamano; M Ohishi; M Ueda; K Fujioka; T Katoh; N Zempo; Y Fujimura; A Okamura; H Rakugi; J Higaki; T Ogihara; K Esato
Journal:  Eur J Vasc Endovasc Surg       Date:  1999-08       Impact factor: 7.069

5.  Progression of abdominal aortic aneurysm towards rupture: refining clinical risk assessment using a fully coupled fluid-structure interaction method.

Authors:  Michalis Xenos; Nicos Labropoulos; Suraj Rambhia; Yared Alemu; Shmuel Einav; Apostolos Tassiopoulos; Natzi Sakalihasan; Danny Bluestein
Journal:  Ann Biomed Eng       Date:  2014-12-20       Impact factor: 3.934

6.  Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms.

Authors:  Toru Ogata; Hidenori Shibamura; Gerard Tromp; Moumita Sinha; Katrina A B Goddard; Natzi Sakalihasan; Raymond Limet; Gerald L MacKean; Claudette Arthur; Taijiro Sueda; Susan Land; Helena Kuivaniemi
Journal:  J Vasc Surg       Date:  2005-06       Impact factor: 4.268

7.  The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.

Authors:  K Jones; J Powell; L Brown; R Greenhalgh; S Jormsjö; P Eriksson
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-05       Impact factor: 7.069

8.  Does the angiotensin-converting enzyme (ACE) gene polymorphism affect rate of abdominal aortic aneurysm expansion?

Authors:  J M C Yeung; M Heeley; S Gray; M K Lingam; G Manning; J R Nash; R Donnelly
Journal:  Eur J Vasc Endovasc Surg       Date:  2002-07       Impact factor: 7.069

9.  The deletion polymorphism of the angiotensin-converting enzyme gene is associated with acute aortic dissection.

Authors:  Nihat Kalay; Okay Caglayan; Hasan Akkaya; Ibrahim Ozdogru; Ali Dogan; Mehmet Tugrul Inanc; Mehmet Gungor Kaya; Ali Ergin; Ramazan Topsakal; Davran Ciçek; Namik Kemal Eryol; Kutay Tasdemir; Abdurrahman Oguzhan; Munis Dundar
Journal:  Tohoku J Exp Med       Date:  2009-09       Impact factor: 1.848

10.  Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis.

Authors:  J U Kim; H K Chang; S S Lee; J W Kim; K T Kim; S W Lee; W T Chung
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.